Mixhael J. Fox Foundation – Innovative Molecular MRI Biomarker Program
Ends on 14 July 2025
This program seeks to advance the development of innovative molecular MRI (mMRI) techniques that directly quantify molecular and cellular events in Parkinson’s disease (PD).